Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Guerini

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 5, 2005
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomerRainer Albert, Klaus Hinterding, Volker Brinkmann, et al.
British Journal of Pharmacology|March 20, 2014
Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalizationDavid A Sykes, Darren M Riddy, Craig Stamp, et al.
Cell Reports|November 10, 2021
TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritisJoschka Willemsen, Marie-Therese Neuhoff, Thomas Hoyler, et al.
Journal of Neurochemistry|May 10, 2007
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptorsFlorian Mullershausen, Luis M Craveiro, Youngah Shin, et al.
Journal of Medicinal Chemistry|January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In VivoJuraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Orally Active Hydroxyethylamine Based SPPL2a InhibitorsJuraj Velcicky, Casey J N Mathison, Victor Nikulin, et al.
Chemistry & Biology|September 25, 2012
A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitisJean Quancard, Birgit Bollbuck, Philipp Janser, et al.
Chemistry & Biology|November 23, 2006
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation modelShifeng Pan, Yuan Mi, Charles Pally, et al.
Nature Communications|May 29, 2024
Small molecule induced STING degradation facilitated by the HECT ligase HERC4Merve Mutlu, Isabel Schmidt, Andrew I Morrison, et al.
Iscience|December 8, 2021
STING regulates peripheral nerve regeneration and colony stimulating factor 1 receptor (CSF1R) processing in microgliaGiulio Morozzi, Julian Rothen, Gauthier Toussaint, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 5, 2005
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomerRainer Albert, Klaus Hinterding, Volker Brinkmann, et al.
British Journal of Pharmacology|March 20, 2014
Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalizationDavid A Sykes, Darren M Riddy, Craig Stamp, et al.
Cell Reports|November 10, 2021
TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritisJoschka Willemsen, Marie-Therese Neuhoff, Thomas Hoyler, et al.
Journal of Neurochemistry|May 10, 2007
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptorsFlorian Mullershausen, Luis M Craveiro, Youngah Shin, et al.
Journal of Medicinal Chemistry|January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In VivoJuraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Orally Active Hydroxyethylamine Based SPPL2a InhibitorsJuraj Velcicky, Casey J N Mathison, Victor Nikulin, et al.
Chemistry & Biology|September 25, 2012
A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitisJean Quancard, Birgit Bollbuck, Philipp Janser, et al.
Chemistry & Biology|November 23, 2006
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation modelShifeng Pan, Yuan Mi, Charles Pally, et al.
Nature Communications|May 29, 2024
Small molecule induced STING degradation facilitated by the HECT ligase HERC4Merve Mutlu, Isabel Schmidt, Andrew I Morrison, et al.
Iscience|December 8, 2021
STING regulates peripheral nerve regeneration and colony stimulating factor 1 receptor (CSF1R) processing in microgliaGiulio Morozzi, Julian Rothen, Gauthier Toussaint, et al.
Pageof 4